SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christoph Schulz, Frank Kullmann, Volker Kunzmann, Martin Fuchs, Michael Geissler, Ursula Vehling-Kaiser, Heribert Stauder, Axel Wein, Salah-Eddin Al-Batran, Thomas Kubin, Claus Schäfer, Sebastian Stintzing, Clemens Giessen, Dominik Paul Modest, Karsten Ridwelski, Volker Heinemann, NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma—Very good response predominantly in patients with intestinal type tumors, International Journal of Cancer, 2015, 136, 11
  2. 2
    Francesco Cellini, Alessio G Morganti, Francesco M Di Matteo, Gian Mattiucci, Vincenzo Valentini, Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach, Radiation Oncology, 2014, 9, 1, 45

    CrossRef

  3. 3
    Koji Tanaka, Yasuhiko Mohri, Yuhki Koike, Yoshinaga Okugawa, Yuji Toiyama, Masaki Ohi, Minako Kobayashi, Yasuhiro Inoue, Toshimitsu Araki, Keiichi Uchida, Chikao Miki, Masato Kusunoki, Molecular characteristics of residual cancer and stromal cells after chemoradiotherapy for gastric cancer: report of four cases, Clinical Case Reports, 2014, 2, 5
  4. 4
    Katja Ott, Susanne Blank, Karen Becker, Rupert Langer, Wilko Weichert, Wilfried Roth, Leila Sisic, Annika Stange, Dirk Jäger, Markus Büchler, Jörg-Rüdiger Siewert, Florian Lordick, Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor, Langenbeck's Archives of Surgery, 2013, 398, 2, 239

    CrossRef

  5. 5
    Roopma Wadhwa, Takashi Taketa, Kazuki Sudo, Mariela A. Blum, Jaffer A. Ajani, Modern Oncological Approaches to Gastric Adenocarcinoma, Gastroenterology Clinics of North America, 2013, 42, 2, 359

    CrossRef

  6. 6
    Ji Yeong An, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Choong Bae Kim, Sung Hoon Noh, Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy, Yonsei Medical Journal, 2013, 54, 4, 888

    CrossRef

  7. 7
    Subhasis Misra, Felipe E. Pedroso, Peter J. DiPasco, Naveenraj L. Solomon, Elisabeth Gennis, Dido Franceschi, Bach Ardalan, Leonidas G. Koniaris, Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?, Journal of Surgical Research, 2012, 178, 2, 623

    CrossRef

  8. 8
    Jeannelyn S. Estrella, Asif Rashid, Jason B. Fleming, Matthew H. Katz, Jeffrey E. Lee, Robert A. Wolf, Gauri R. Varadhachary, Peter W. T. Pisters, Eddie K. Abdalla, Jean-Nicolas Vauthey, Hua Wang, Henry F. Gomez, Douglas B. Evans, James L. Abbruzzese, Huamin Wang, Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation, Cancer, 2012, 118, 1
  9. 9
    Sylvie Lorenzen, Susanne Blank, Florian Lordick, Jörg-Rüdiger Siewert, Katja Ott, Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients, Annals of Surgical Oncology, 2012, 19, 7, 2119

    CrossRef

  10. 10
    Koji Tanaka, Susumu Saigusa, Yuji Toiyama, Yuki Koike, Yoshinaga Okugawa, Takeshi Yokoe, Yasuhiro Inoue, Minako Kobayashi, Chikao Miki, Masato Kusunoki, TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy, Journal of Surgical Oncology, 2012, 105, 6
  11. 11
    JERROLD R. TURNER, Robbins and Cotran Pathologic Basis of Disease, 2010,

    CrossRef

  12. 12
    Fernando Rivera, Maica Galán, Josep Tabernero, Andres Cervantes, M. Eugenia Vega-Villegas, Javier Gallego, Berta Laquente, Edith Rodríguez, Alfredo Carrato, Pilar Escudero, Bartomeu Massutí, Vicente Alonso-Orduña, Adelaida Cardenal, Alberto Sáenz, Jordi Giralt, Ana Lucia Yuste, Antonio Antón, Enrique Aranda, Phase II Trial of Preoperative Irinotecan–Cisplatin Followed by Concurrent Irinotecan–Cisplatin and Radiotherapy for Resectable Locally Advanced Gastric and Esophagogastric Junction Adenocarcinoma, International Journal of Radiation Oncology*Biology*Physics, 2009, 75, 5, 1430

    CrossRef

  13. 13
    Hany Elsaleh, James J Farrell, Christopher H Crane, Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?, Journal of Gastroenterology and Hepatology, 2009, 24, 5
  14. 14
    Sook Ryun Park, Jong Seok Lee, Chan Gyoo Kim, Hark Kyun Kim, Myeong-Cherl Kook, Young-Woo Kim, Keun Won Ryu, Jun Ho Lee, Jae-Moon Bae, Il Ju Choi, Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer, Cancer, 2008, 112, 11
  15. 15
    Yoshiro Saikawa, Tetsuro Kubota, Koshi Kumagai, Rieko Nakamura, Koichiro Kumai, Naoyuki Shigematsu, Atsushi Kubo, Masaki Kitajima, Yuko Kitagawa, Phase II Study of Chemoradiotherapy With S-1 and Low-Dose Cisplatin for Inoperable Advanced Gastric Cancer, International Journal of Radiation Oncology*Biology*Physics, 2008, 71, 1, 173

    CrossRef

  16. 16
    Jaffer A. Ajani, Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!, Annals of Surgical Oncology, 2007, 14, 12, 3290

    CrossRef

  17. 17
    Vincenzo Valentini, Francesco Cellini, Radiotherapy in gastric cancer: a systematic review of literature and new perspectives, Expert Review of Anticancer Therapy, 2007, 7, 10, 1379

    CrossRef

  18. 18
    J. R. Siewert, F. Lordick, Response-Vorhersage – frühe Response-Evaluation, Der Chirurg, 2006, 77, 12, 1095

    CrossRef